anti erbb2 monoclonal antibody (OriGene)
Structured Review

Anti Erbb2 Monoclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti erbb2 monoclonal antibody/product/OriGene
Average 93 stars, based on 9 article reviews
Images
1) Product Images from "Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia"
Article Title: Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia
Journal: Molecular Therapy Oncology
doi: 10.1016/j.omton.2025.201060
Figure Legend Snippet: Analysis of the membrane expression of ErbB1, ErbB2, ErbB3, and ErbB4 molecules in FA-proficient and FA-deficient HNSCC cell lines Left and right axes represent, respectively, the percentage of ErbB positive cells and the specific fluorescence intensity (SFI) corresponding to each ErbB receptor. (A) FA-proficient HNSCCs cell lines. (B) FA-deficient HNSCCs cell lines. SFI expression levels of the different ErbB members were obtained as the ratio between the mean fluorescence intensity (MFI) after staining with the corresponding monoclonal antibody (MoAb) relative to MFI obtained with the control isotype. Bars show the mean ± SEM ( n = 3). (C) Representative flow cytometry analysis of ErbB1-ErbB4 receptors in HNSCCs (VU-1131). FA-A and FA-C represent FA complementation groups with mutations in FANCA and FANCC, respectively.
Techniques Used: Membrane, Expressing, Fluorescence, Staining, Control, Flow Cytometry